Flow cytometric measurement of calpain activity in living cells

Cytometry Part A

Volumn 71, Issue 7, 2007, Pages 475-485

  Niapour, Maryam ^a,b   Berger, Stuart ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Blood; Calcium; Calpain; Flow cytometry; PDGF leukemia

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 (4 IODOPHENYL) 2 MERCAPTO 2 PROPENOIC ACID; ACRYLIC ACID; CALCIUM; CALPAIN; METHIONINE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR; REAGENT; TERT BUTYLOXYCARBONYLLEUCYLMETHIONINAMIDE; THIOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DIFFUSION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KINETICS; NONHUMAN; PRIORITY JOURNAL; RAT; RELIABILITY; UMBILICAL CORD BLOOD;

ACRYLATES; ANIMALS; CALPAIN; CELLS, CULTURED; COUMARINS; DIPEPTIDES; ENZYME ACTIVATION; FETAL BLOOD; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; KINETICS; MODELS, BIOLOGICAL; PLATELET-DERIVED GROWTH FACTOR; RATS; SUBSTRATE SPECIFICITY; TEMPERATURE;

EID: 34447115066     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20399     Document Type: Article

References (66)

1. Franco S, Perrin B, Huttenlocher A. Isoform specific function of calpain 2 in regulating membrane protrusion. Exp Cell Res 2004;299:179-187.
2. Franco SJ, Huttenlocher A. Regulating cell migration: Calpains make the cut. J Cell Sci 2005;118:3829-3838.
3. Hussain AM, Zhang QX, Murray AG. Endothelial cell calpain activity facilitates lymphocyte diapedesis. Am J Transplant 2005;5:2640-2648.
4. Carragher NO, Fonseca BD, Frame MC. Calpain activity is generally elevated during transformation but has oncogene-specific biological functions. Neoplasia 2004;6:53-73.
5. Concha C, Monardes A, Even Y, Morin V, Puchi M, Imschenetzky M, Geneviere AM. Inhibition of cysteine protease activity disturbs DNA replication and prevents mitosis in the early mitotic cell cycles of sea urchin embryos. J Cell Physiol 2005;204:693-703.
6. Raynaud F, Carnac G, Marcilhac A, Benyamin Y. m-Calpain implication in cell cycle during muscle precursor cell activation. Exp Cell Res 2004;298:48-57.
7. Harwood SM, Yaqoob MM, Allen DA. Caspase and calpain function in cell death: Bridging the gap between apoptosis and necrosis. Ann Clin Biochem 2005;42:415-431.
8. Dursun B, He Z, Somerset H, Oh D-J, Faubel S, Edelstein CL. Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis. Am J Physiol Renal Physiol 2006;291:F578-F587.
9. Lescop C, Herzner H, Siendt H, Bolliger R, Hennebohle M, Weyermann P, Briguet A, Courdier-Fruh I, Erb M, Foster M, Meier T, Magyar JP, von Sprecher A. Novel cell-penetrating et-keto-amide calpain inhibitors as potential treatment for muscular dystrophy. Bioorg Med Chem Lett 2005;15:5176-5181.
10. Yoshikawa Y, Mukai H, Hino F, Asada K, Kato I. Isolation of two novel genes, down-regulated in gastric cancer. Jpn J Cancer Res 2000;91:459-463.
11. Lakshmikuttyamma A, Selvakumar P, Kanthan R, Kanthan SC, Sharma RK. Overexpression of m-calpain in human colorectal adenocarcinomas. Cancer Epidemiol Biomarkers Prev 2004;13:1604-1609.
12. Biswas SH, FSingh, J Phoenix D. Role of calpains in diabetes mellitus-induced cataractogenesis: A mini review. Mol Cell Biochem 2004;261:151-159.
13. Battaglia F, Trinchese F, Liu S, Walter S, Nixon RA, Arancio O. Calpain inhibitors, a treatment for Alzheimer's disease: Position paper. J Mol Neurosci 2003;20:357-362.
14. Huang Y, Wang KK. The calpain family and human disease. Trends Mol Med 2001;7:355-362.
15. Azarian SM, Williams DS. Calpain activity in the retinas of normal and RCS rats. Curr Eye Res 1995;14:731-735.
16. Tamada Y, Fukiage C, Mizutani K, Yamaguchi M, Nakamura Y, Azuma M, Shearer TR. Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats. Curr Eye Res 2001;22:280-285.
17. Enns D, Karmazyn M, Mair J, Lercher A, Kountchev J, Belcastro A. Calpain, calpastatin activities and ratios during myocardial ischemia-reperfusion. Mol Cell Biochem 2002;241:29-35.
18. Khalil PN, Neuhof C, Huss R, Pollhammer M, Khalil MN, Neuhof H, Fritz H, Siebeck M. Calpain inhibition reduces infarct size and improves global hemodynamics and left ventricular contractility in a porcine myocardial ischemia/reperfusion model. Eur J Pharmacol 2005;528:124-131.
19. Shields DC, Schaecher KE, Saido TC, Banik NL. A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc Natl Acad Sci USA 1999;96:11486-11491.
20. Rami A. Ischemic neuronal death in the rat hippocampus: The calpain-calpastatin-caspase hypothesis. Neurobiol Dis 2003;13:75-88.
21. 2+, ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid. Neurochem Int 2003;43:89-99.
22. Ray SK, Banik NL. Calpain and its involvement in the pathophysiology of CNS injuries and diseases: Therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord 2003;2:173-189.
23. Seyfried DM, Veyna R, Han Y, Li K, Tang N, Betts RL, Weinsheimer S, Chopp M, Anagli J. A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia. Brain Res 2001;901:94-101.
24. Mundo E, Soldati L, Bellodi L, Bianchi G. The calpain-calpastatin system in obsessive-compulsive disorder. Biol Psychiatry 1997;42:228-229.
25. Chera B, Schaecher KE, Rocchini A, Imam SZ, Sribnick EA, Ray SK, Ali SF, Banik NL. Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mice. Brain Res 2004;1006:150-156.
26. Ray SK, Hogan EL, Banik NL. Calpain in the pathophysiology of spinal cord injury: Neuroprotection with calpain inhibitors. Brain Res Brain Res Rev 2003;42:169-185.
27. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 2003;83:731-801.
28. Ono Y, Sorimachi H, Suzuki K. Structure and physiology of calpain, an enigmatic protease. Biochem Biophys Res Commun 1998;245:289-294.
29. Tan Y, Dourdin N, Wu C, De Veyra T, Elce JS, Greer PA. Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis. J Biol Chem 2006;281:16016-16024.
30. Friedrich P, Bozoky Z. Digestive versus regulatory proteases: On calpain action in vivo. Biol Chem 2005;386:609-612.
31. Schaecher K, Goust JM, Banik NL. The effects of calpain inhibition on IkB α degradation after activation of PBMCs: Identification of the calpain cleavage sites. Neurochem Res 2004;29:1443-1451.
32. Betts RA, Anagli J. The β- and γ-CH2 of B27-WT's Leu11 and Ile18 side chains play a direct role in calpain inhibition. Biochemistry 2004;43:2596-2604.
33. Betts R, Weinsheimer S, Blouse GE, Anagli J. Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT. J Biol Chem 2003;278:7800-7809.
34. Perrin BJ, Huttenlocher A. Calpain. Int J Biochem Cell Biol 2002;34:722-724.
35. Li H, Thompson VF, Goll DE. Effects of autolysis on properties of μ-and m-calpain. Biochim Biophys Acta 2004;1691:91-103.
36. Glading A, Uberall F, Keyse SM, Lauffenburger DA, Wells A. Membrane proximal ERK signaling is required for M-calpain activation down-stream of epidermal growth factor receptor signaling. J Biol Chem 2001;276:23341-23348.
37. Ma H, Fukiage C, Kim YH, Duncan MK, Reed NA, Shih M, Azuma M, Shearer TR. Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization. J Biol Chem 2001;276:28525-28531.
38. Garcia M, Bondada V, Geddes JW. Mitochondrial localization of μ-calpain. Biochem Biophys Res Commun 2005;338:1241-1247.
39. Gil-Parrado S, Popp O, Knoch TA, Zahler S, Bestvater F, Felgentrager M, Holloschi A, Fernandez-Montalvan A, Auerswald EA, Fritz H, Fuentes-Prior P, Machleidt W, Spiess E. Subcellular localization and in vivo subunit interactions of ubiquitous μ-calpain. J Biol Chem 2003;278:16336-16346.
40. Shao H, Chou J, Baty CJ, Burke NA, Watkins SC, Stolz DB, Wells A. Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation. Mol Cell Biol 2006;26:5481-5496.
41. Kulkarni S, Fox JE. Localization of calpain by immunofluorescence in adherent cells. Methods Mol Biol 2000;144:151-159.
42. Wendt A, Thompson VF, Goll DE. Interaction of calpastatin with calpain: A review. Biol Chem 2004;385:465-472.
43. Zhao X, Newcomb JK, Posmantur RM, Wang KK, Pike BR, Hayes RL. pH dependency of μ-calpain and m-calpain activity assayed by casein zymography following traumatic brain injury in the rat. Neurosci Lett 1998;247:53-57.
44. Tompa P, Schad E, Friedrich P. A sensitive and continuous fluorometric activity assay using a natural substrate. Microtubule-associated protein 2. Methods Mol Biol 2000;144:137-141.
45. Rosser BG, Powers SP, Gores GJ. Calpain activity increases in hepatocytes following addition of ATP Demonstration by a novel fluorescent approach. J Biol Chem 1993;268:23593-23600.
46. Sasaki T, Kikuchi T, Yumoto N, Yoshimura N, Murachi T. Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates. J Biol Chem 1984;259:12489-12494.
47. Mittoo S, Sundstrom LE, Bradley M. Synthesis and evaluation of fluorescent probes for the detection of calpain activity. Anal Biochem 2003;319:234-238.
48. Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR. Tumor necrosis factor-α-inducible IκBCα proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-κb activation. J Biol Chem 1999;274:787-794.
49. Lokuta MA, Nuzzi PA, Huttenlocher A. Calpain regulates neutrophil chemotaxis. Proc Natl Acad Sci USA 2003;100:4006-4011.
50. Rosser BG, Gores GJ. Cellular in vivo assay of calpain activity using a fluorescent substrate. Application to study of anoxic liver injury. Methods Mol Biol 2000;144:245-259.
51. Chatterjee PK, Todorovic Z, Sivarajah A, Mota-Filipe H, Brown PA, Stewart KN, Mazzon E, Cuzzocrea S, Thiemermann C. Inhibitors of calpain activation (PD150606 and E-64) and renal ischemia-reperfusion injury. Biochem Pharmacol 2005;69:1121-1131.
52. Montero A, Alonso M, Benito E, Chana A, Mann E, Navas JM, Herradon B. Studies on aromatic compounds: Inhibition of calpain I by biphenyl derivatives and peptide-biphenyl hybrids. Bioorg Med Chem Lett 2004;14:2753-2757.
53. Farkas B, Tantos A, Schlett K, Vilagi I, Friedrich P. Ischemia-induced increase in long-term potentiation is warded off by specific calpain inhibitor PD150606. Brain Res 2004;1024:150-158.
54. 2+ influx and not via calpain inhibition. Neuropharmacology 2002;42:706-713.
55. Arai K, Lee SR, van Leyen K, Kurose H, Lo EH. Involvement of ERK MAP kinase in endoplasmic reticulum stress in SH-SY5Y human neuroblastoma cells. J Neurochem 2004;89:232-239.
56. Smith KD, Wells A, Lauffenburger DA. Multiple signaling pathways mediate compaction of collagen matrices by EGF-stimulated fibroblasts. Exp Cell Res 2006;312:1970-1982.
57. Neron S, Dussault N, Racine C. Whole-blood leukoreduction filters are a source for cryopreserved cells for phenotypic and functional investigations on peripheral blood lymphocytes. Transfusion 2006;46:537-544.
58. O'Brien RM, Kemeny DM. Distribution of alloreactivity amongst the CD45 isoforms of circulating CD4 and CD8 T lymphocytes. Scand J Immunol 1998;48:679-683.
59. Pellat-Deceunynck C, Bataille R. Normal and malignant human plasma cells: Proliferation, differentiation, and expansions in relation to CD45 expression. Blood Cells Mol Dis 2004;32:293-301.
60. Tytherleigh L, Taparia M, Leahy MF. Detection of hairy cell leukaemia in blood and bone marrow using multidimensional flow cytometry with CD45-PECy5 and SS gating. Clin Lab Haematol 2001;23:385-390.
61. Stockholm D, Bartoli M, Sillon G, Bourg N, Davoust J, Richard I. Imaging calpain protease activity by multiphoton FRET in living mice. J Mol Biol 2005;346:215-222.
62. Thompson VF, Saldana S, Cong J, Goll DE. A BODIPY fluorescent microplate assay for measuring activity of calpains and other pro-teases. Anal Biochem 2000;279:170-178.
63. Tripathy R, Ator MA, Mallamo JP. Calpain inhibitors based on the quiescent affinity label concept: High rates of calpain inactivation with leaving groups derived from N-hydroxy peptide coupling reagents. Bioorg Med Chem Lett 2000;10:2315-2319.
64. Wang KK, Nath R, Posner A, Raser KJ, Buroker-Kilgore M, Hajimohammadreza I, Probert AWJ, Marcoux FW, Ye Q, Takano E, Hatanaka M, Maki M, Caner H, Collins JL, Fergus A, Lee KS, Lunney EA, Hays SJ, Yuen P. An α-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proc Natl Acad Sci USA 1996;93:6687-6692.
65. Upadhya GA, Topp SA, Hotchkiss RS, Anagli J, Strasberg SM. Effect of cold preservation on intracellular calcium concentration and calpain activity in rat sinusoidal endothelial cells. Hepatology 2003;37:313-323.
66. Nakajima E, Walkup RD, Ma H, Shearer TR, Azuma M. Low activity by the calpain system in primate lenses causes resistance to calcium-induced proteolysis. Exp Eye Res 2006;83:593-601.